GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioNeutra Global Corp (TSXV:BGA) » Definitions » Debt-to-Asset

BioNeutra Global (TSXV:BGA) Debt-to-Asset : 0.53 (As of Jun. 2024)


View and export this data going back to 1999. Start your Free Trial

What is BioNeutra Global Debt-to-Asset?

BioNeutra Global's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was C$0.61 Mil. BioNeutra Global's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was C$6.97 Mil. BioNeutra Global's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2024 was C$14.36 Mil. BioNeutra Global's debt to asset for the quarter that ended in Jun. 2024 was 0.53.


BioNeutra Global Debt-to-Asset Historical Data

The historical data trend for BioNeutra Global's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNeutra Global Debt-to-Asset Chart

BioNeutra Global Annual Data
Trend Feb14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.22 0.30 0.33 0.35 0.49

BioNeutra Global Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.44 0.45 0.49 0.49 0.53

Competitive Comparison of BioNeutra Global's Debt-to-Asset

For the Packaged Foods subindustry, BioNeutra Global's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioNeutra Global's Debt-to-Asset Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, BioNeutra Global's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where BioNeutra Global's Debt-to-Asset falls into.



BioNeutra Global Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

BioNeutra Global's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

BioNeutra Global's Debt-to-Asset for the quarter that ended in Jun. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioNeutra Global  (TSXV:BGA) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


BioNeutra Global Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of BioNeutra Global's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


BioNeutra Global Business Description

Traded in Other Exchanges
Address
9608 - 25 Avenue NW, Edmonton, AB, CAN, T6N 1J4
BioNeutra Global Corp is engaged in the research, development, production, and commercialization of food ingredients for neutraceutical, functional and mainstream foods, focusing on oligosaccharides. Its product portfolio provides ingredients for various food systems, that contribute to human nutrition and wellness in functional and healthy foods. Its prime product, VitaFiber IMO, is offered in both powder and syrup form. The company operates in Canada while generating sales revenue from various countries internationally. It has a single industry segment, manufacturing and trading of products. The majority of the revenue is derived from the United States.
Executives
Monica Barclay Senior Officer

BioNeutra Global Headlines

No Headlines